newsfilter
← Latest News
Business Wire·

Anacor Pharmaceuticals Appoints Wendell Wierenga to Its Board of Directors

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) today announced that its Board of Directors has appointed Wendell Wierenga, Ph.D. to serve as a Class III director until the Company’s 2016 annual meeting of shareholders. Anacor also announced that Paul Klingenstein has resigned from the Board.